Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | - USD | -62.35% |
| 2019 | -116.74 Thousand USD | 30.15% |
| 2018 | - USD | -252.16% |
| 2017 | -526.22 Thousand USD | -212.83% |
| 2016 | 1.13 Million USD | 43.61% |
| 2015 | - USD | 0.0% |
| 2012 | -2.54 Million USD | -609.93% |
| 2011 | -1.14 Million USD | -127.33% |
| 2010 | 784.3 Thousand USD | 426.1% |
| 2009 | -427.86 Thousand USD | -161.6% |
| 2008 | 694.59 Thousand USD | 169.06% |
| 2007 | -1.05 Million USD | 45.17% |
| 2006 | -2.08 Million USD | -6.39% |
| 2005 | -3.77 Million USD | -30.5% |
| 2004 | -2.89 Million USD | 25.17% |
| 2003 | -1.84 Million USD | 4.92% |
| 2002 | -2.88 Million USD | -981.31% |
| 2001 | -4974.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | -237.36 Thousand USD | 47.72% |
| 2021 Q3 | -490.72 Thousand USD | -106.73% |
| 2021 Q1 | -454.01 Thousand USD | 39.5% |
| 2020 FY | - USD | -62.35% |
| 2020 Q1 | -607.17 Thousand USD | -1149.8% |
| 2020 Q2 | -397 Thousand USD | 34.61% |
| 2020 Q3 | -346.82 Thousand USD | 12.64% |
| 2020 Q4 | -750.43 Thousand USD | -116.38% |
| 2019 Q4 | 57.83 Thousand USD | 120.23% |
| 2019 Q3 | -285.92 Thousand USD | 25.3% |
| 2019 FY | - USD | 30.15% |
| 2019 Q2 | -382.75 Thousand USD | 44.47% |
| 2019 Q1 | -689.28 Thousand USD | -1632.14% |
| 2018 Q1 | -53.4 Thousand USD | 63.76% |
| 2018 Q4 | -39.79 Thousand USD | 71.32% |
| 2018 FY | - USD | -252.16% |
| 2018 Q2 | -154.13 Thousand USD | -188.6% |
| 2018 Q3 | -138.74 Thousand USD | 9.99% |
| 2017 Q2 | -150.34 Thousand USD | -87.02% |
| 2017 Q1 | -80.39 Thousand USD | -12.06% |
| 2017 FY | - USD | -212.83% |
| 2017 Q4 | -147.37 Thousand USD | 0.49% |
| 2017 Q3 | -148.1 Thousand USD | 1.49% |
| 2016 Q3 | -311.64 Thousand USD | -198.05% |
| 2016 FY | - USD | 43.61% |
| 2016 Q4 | -71.74 Thousand USD | 76.98% |
| 2016 Q2 | 317.82 Thousand USD | 409.6% |
| 2016 Q1 | -102.65 Thousand USD | -29.76% |
| 2015 Q2 | -67.27 Thousand USD | 77.02% |
| 2015 Q4 | -79.11 Thousand USD | -25.34% |
| 2015 Q3 | -63.11 Thousand USD | 6.18% |
| 2015 Q1 | -292.78 Thousand USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q2 | -163.82 Thousand USD | -162.01% |
| 2014 Q1 | -62.52 Thousand USD | 0.0% |
| 2013 Q3 | -217.07 Thousand USD | 79.08% |
| 2013 Q2 | -1.03 Million USD | -243.85% |
| 2013 Q1 | -301.73 Thousand USD | 84.3% |
| 2012 Q4 | -1.92 Million USD | -1117.86% |
| 2012 Q2 | -626.72 Thousand USD | -61890.7% |
| 2012 Q3 | -157.81 Thousand USD | 74.82% |
| 2012 Q1 | -1011.00 USD | 99.86% |
| 2012 FY | - USD | -609.93% |
| 2011 Q4 | -721.24 Thousand USD | -279.49% |
| 2011 Q2 | 664.83 Thousand USD | 679.72% |
| 2011 Q1 | -114.68 Thousand USD | -120.34% |
| 2011 FY | - USD | -127.33% |
| 2011 Q3 | -190.05 Thousand USD | -128.59% |
| 2010 Q2 | 313.01 Thousand USD | 52.91% |
| 2010 Q3 | 343.49 Thousand USD | 9.74% |
| 2010 FY | - USD | 426.1% |
| 2010 Q4 | 563.94 Thousand USD | 64.18% |
| 2010 Q1 | 204.7 Thousand USD | -63.75% |
| 2009 Q2 | -1.21 Million USD | -763.53% |
| 2009 Q3 | 40.78 Thousand USD | 103.35% |
| 2009 Q4 | 564.69 Thousand USD | 1284.42% |
| 2009 FY | - USD | -161.6% |
| 2009 Q1 | 183.36 Thousand USD | -44.29% |
| 2008 Q2 | 222.9 Thousand USD | 7.12% |
| 2008 Q4 | 329.17 Thousand USD | 151.69% |
| 2008 Q3 | 130.78 Thousand USD | -41.33% |
| 2008 Q1 | 208.08 Thousand USD | 139.94% |
| 2008 FY | - USD | 169.06% |
| 2007 Q4 | -520.99 Thousand USD | -483.88% |
| 2007 Q3 | -89.23 Thousand USD | 62.54% |
| 2007 Q2 | -238.2 Thousand USD | -46.72% |
| 2007 Q1 | -162.35 Thousand USD | 88.05% |
| 2007 FY | - USD | 45.17% |
| 2006 Q2 | -250.33 Thousand USD | -210.3% |
| 2006 Q3 | -441.72 Thousand USD | -76.46% |
| 2006 Q4 | -1.35 Million USD | -207.67% |
| 2006 FY | - USD | -6.39% |
| 2006 Q1 | 226.95 Thousand USD | 130.99% |
| 2005 Q1 | -537.85 Thousand USD | -201.28% |
| 2005 Q2 | 182.77 Thousand USD | 133.98% |
| 2005 Q4 | -732.42 Thousand USD | -334.25% |
| 2005 Q3 | -168.66 Thousand USD | -192.28% |
| 2005 FY | - USD | -30.5% |
| 2004 FY | - USD | 25.17% |
| 2004 Q3 | -723.89 Thousand USD | 14.66% |
| 2004 Q2 | -848.22 Thousand USD | -457.57% |
| 2004 Q1 | -152.12 Thousand USD | 84.7% |
| 2004 Q4 | 531.04 Thousand USD | 173.36% |
| 2003 Q3 | -225.33 Thousand USD | -23.26% |
| 2003 Q1 | -359.82 Thousand USD | 60.0% |
| 2003 Q2 | -199.63 Thousand USD | 54.83% |
| 2003 FY | - USD | 4.92% |
| 2003 Q4 | -1 Million USD | -396.23% |
| 2002 Q2 | -293.72 Thousand USD | -100.04% |
| 2002 Q4 | -857.04 Thousand USD | -145.61% |
| 2002 Q3 | -434.58 Thousand USD | -24.97% |
| 2002 FY | - USD | -981.31% |
| 2002 Q1 | -146.49 Thousand USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | 100.0% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | 100.0% |
| Health Advance Inc. | -47.95 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | -1.27 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | 100.0% |
| MedGen, Inc. | -15.37 USD | 100.0% |
| Omni Health, Inc. | 1.28 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | 100.0% |
| Pineapple, Inc. | -1.47 Million USD | 100.0% |
| ScripsAmerica, Inc. | -3.95 Million USD | 100.0% |